1. $ALXN Incredible value here. One of the best biotech companies in the world on sale. CRAZY sale.

  2. $GILD $ACT $JAZZ $ALXN $MRK With the whole sector selling off it appears there is a buying opportunity in some high quality names.

  3. $ALXN looks attractive (rated 7.0 as price is down to 167.89). Price vs ratings chart: https://www.v2ratings.com/ratings/t/alxn

  4. Biotechs returning from the stratosphere. Buying opps down the road. Pipelines still good. $GILD $AMGN $BIIB $CELG $REGN $ALXN $VRTX $ILMN

  5. $ALXN Assets are Growing. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Assets+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  6. Alexion Pharmaceuticals (ALXN) Stock: Weak On High Volume Today $ALXN http://www.thestreet.com/story/13098435/1/alexion-pharmaceuticals-alxn-stock-weak-on-high-volume-today.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  7. Q1 was fun. Starting roster for Q2: $AMGN $GILD $ILMN $ALXN $REGN $VRTX $VRX $BLUE $ONCE $IDRA

  8. $ALXN Revenue is Growing. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  9. $ALXN looks attractive (rated 7.2 as price is down to 174.61). Price vs ratings chart: https://www.v2ratings.com/ratings/t/alxn

  10. Tuesday Sector Laggards: Healthcare, Utilities $CLEG $ALXN $XLV $FE $TE https://www.theonlineinvestor.com/article/201503/tuesday-sector-laggards-healthcare-utilities-celg-alxn-xlv-fe-te-XLV03312015spxldr.htm/

  11. $ALXN Dropping hard, way (way) through MAs. Great company, rough stock. Here s what I m looking at http://lite.capitalmarketlabs.com/cmld3b/stock_alxn.php

  12. $ALXN Do people realize that the FDA approval is imminent. The pipeline of orphan indications is incredible? Thanks dummies.

  13. Roof Leaker To Watch: Alexion Pharmaceuticals (ALXN) $ALXN http://www.thestreet.com/story/13097173/1/roof-leaker-to-watch-alexion-pharmaceuticals-alxn.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  14. $ALXN Bidding here May 17 175 calls 9.1

  15. $ALXN Revenue is Increasing. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  16. $ALXN vs. $BIIB vs. $PCYC vs. $GILD Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=ALXN|BIIB|PCYC|GILD|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. $ALXN Assets are Increasing. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Assets+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  18. UPDATED SUPPORT: Sunday Stock Report Portfolio $STE $ACHC $CAVM $SKX $ULTA $BIIB $MNK $ABC $ALXN $STZ $PEB $VIPS $ACT

  19. $PEB and $ALXN are currently our technically weakest holdings.

  20. $ALXN interested to see how this one acts this week. continues to defend the 200.

  21. $ALXN vs. $PCYC vs. $GILD vs. $REGN Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=ALXN|PCYC|GILD|REGN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. iShares Nasdaq Biotechnology ETF $IBB +14.54% YTD Top Ten Holdings $BIIB $CELG $GILD $AMGN $REGN $ILMN $VRTX $ALXN $MYL $PCYC

  23. @OphirGottlieb $ALXN Revenue is Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  24. $ALXN Revenue is Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=ALXN&financial_bar=Revenue+(TTM+US$+Millions)&financial_line=Revenue+(TTM+US$+Millions)&start_date=12/31/2005&end_date=12/31/2014&show_line=false&sk=c1a020550c6dabc24726f32636311b5c

  25. $CELG vs. $REGN vs. $ALXN vs. $AMGN Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=CELG|REGN|ALXN|AMGN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)